Jin H. Hwang

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications

Clinical outcomes and feasibility of nonthermal, nontumescent ablation for isolated below-the-knee great saphenous vein incompetence.

Clinical outcomes and feasibility of nonthermal, nontumescent ablation for isolated below-the-knee great saphenous vein incompetence.

Journal: Journal of vascular surgery. Venous and lymphatic disorders
Published: February 03, 2026

Transarterial embolization for chronic wrist pain: a preliminary study of feasibility, safety, and pain reduction.

Transarterial embolization for chronic wrist pain: a preliminary study of feasibility, safety, and pain reduction.

Journal: CVIR endovascular
Published: January 26, 2026

K-SALT Equation for Urinary Sodium Estimation in CKD.

K-SALT Equation for Urinary Sodium Estimation in CKD.

Journal: Kidney international reports
Published: January 23, 2026

Optimizing hemodialysis management using bioelectrical impedance analysis: emphasizing the significance of the phase angle.

Optimizing hemodialysis management using bioelectrical impedance analysis: emphasizing the significance of the phase angle.

Journal: Renal failure
Published: October 06, 2025

A comparative study of oxidative stress, vascular calcification, and volume status in non-dippers and dippers receiving maintenance hemodialysis.

A comparative study of oxidative stress, vascular calcification, and volume status in non-dippers and dippers receiving maintenance hemodialysis.

Journal: Kidney research and clinical practice
Published: October 17, 2024

Radiofrequency ablation for the treatment of great saphenous venous insufficiency using a newly developed VENISTAR catheter: A preliminary study.

Radiofrequency ablation for the treatment of great saphenous venous insufficiency using a newly developed VENISTAR catheter: A preliminary study.

Journal: Vascular
Published: April 25, 2024

In CKD, empagliflozin reduced kidney disease progression at a median 2 y, regardless of primary kidney disease type.

In CKD, empagliflozin reduced kidney disease progression at a median 2 y, regardless of primary kidney disease type.

Journal: Annals of internal medicine
Published: April 01, 2024

A "Fit for Purpose" Approach to CKD Classification?

A "Fit for Purpose" Approach to CKD Classification?

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: December 12, 2023

Unveiling the role of transgelin as a prognostic and therapeutic target in kidney fibrosis via a proteomic approach.

Unveiling the role of transgelin as a prognostic and therapeutic target in kidney fibrosis via a proteomic approach.

Journal: Experimental & molecular medicine
Published: December 06, 2023

Thiazide-associated hyponatremia in arterial hypertension patients: A nationwide population-based cohort study.

Thiazide-associated hyponatremia in arterial hypertension patients: A nationwide population-based cohort study.

Journal: Journal of evidence-based medicine
Published: November 05, 2023

Comparison of the performance of currently used estimated glomerular filtration rate equations with 24-hour urine creatinine clearance: sample analysis of randomised controlled trial participants.

Comparison of the performance of currently used estimated glomerular filtration rate equations with 24-hour urine creatinine clearance: sample analysis of randomised controlled trial participants.

Journal: BMJ open
Published: August 23, 2023

De Novo ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis After COVID-19 mRNA Vaccination: A Case Report.

De Novo ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis After COVID-19 mRNA Vaccination: A Case Report.

Journal: Journal of Korean medical science
Published: June 06, 2023
Showing 1-12 of 106

Last Updated: 09/26/2026